Log in or Sign up for Free to view tailored content for your specialty!
Cirrhosis/Liver Failure News
AASLD invests $4.06 million in liver disease research, development
The American Association for the Study of Liver Diseases Foundation announced its investment of $4.06 million in research and career development grants awarded to 36 researchers and clinicians, according to a press release.
Women’s health in hepatology: 7 recent reports
Studies that focus on specific patient characteristics and demographics often reveal key strategies to improve health care at the individual patient level. Liver disease research focused on women and mothers has shown that women face fertility risks with hepatitis C and higher risks for liver injury or failure with chronic liver disease.
Log in or Sign up for Free to view tailored content for your specialty!
Global coverage of HBV treatment remains low despite declining costs
The international market price of generic tenofovir, prequalified by WHO for hepatitis B virus infection, declined more than 85% from 2004 to 2016, according to recent MMWR data. Still, only one in six patients diagnosed with HBV infection worldwide received treatment in 2016.
MRI-PDFF suboptimal in identifying advanced NASH, fibrosis
Results of a study on liver histology features in patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis revealed that magnetic resonance imaging-estimated proton density fat fraction was suboptimal in identifying patients with advanced NASH or fibrosis.
Preconception hepatic scores predict pregnancy outcomes in women with CLD
Preconception albumin-bilirubin score and aspartate aminotransferase to platelet ratio index accurately predicted pregnancy outcomes in women with chronic liver disease, according to recently published data.
Cirrhosis-related mortality rates increasing in U.S. since 2009
Cirrhosis-related mortality increased in the U.S. since 2009 with rates varying by age, ethnicity and region, according to a recently published report.
CARTO technique safe, effective for overt hepatic encephalopathy
Coil-assisted retrograde transvenous obliteration was safe and effective in treating patients with refractory overt hepatic encephalopathy caused by spontaneous portosystemic shunts, according to recently published data.
HBV therapy nonadherence increases risk for liver-related complications
Medication nonadherence among patients with hepatitis B increased the risk for hepatocellular carcinoma, cirrhotic complications and all-cause mortality, according to recently published data.
Expert strategy identifies etiology in indeterminate acute liver failure cases
Researchers were able to establish an etiologic diagnosis among nearly 50% of patients with previously indeterminate etiology of acute liver failure using a systematic analysis strategy that included diagnostic algorithms and expert opinion.
Liver disease mortality highest in U.S. southwest, Hispanic populations
Liver disease-related mortality rates varied significantly by geographic region in the Untied States with some of the highest rates in the South and the West, in areas with higher Hispanic populations, and areas of lower household income, according to a recently published study.
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read